Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03511430 · ClinicalTrials.gov registry record
"SVEAT" Chest Pain Scoring System
A clinical trial, sponsored by University of Nevada, Reno.
- Completed
- Registry status
- 370
- Enrollment target
NCT03511430 is a clinical trial that has completed, run by University of Nevada, Reno. The registered enrollment target is 370 participants.
The verdict
NCT03511430 has completed, sponsored by University of Nevada, Reno.
- COMPLETED
- Registry status
- 370 participants
- Enrollment target
Study Summary
This is a prospective, observational study to assess the efficacy of the newly developed SVEAT scoring system in identifying low-risk patients who may be eligible for early discharge. Various elements of clinical information including Symptoms, Vascular history, EKG, Age and Troponin values will be checked and entered on the scoring form to calculate the SVEAT risk score. Additionally, HEART score and TIMI risk score will be calculated for the same subjects. The primary aim is to assess the positive and negative predictive values for the SVEAT index for cardiovascular events and compare it to the HEART and TIMI Scores.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 370 participants |
| Start Date | 2017-05-01 |
| Est. Completion | 2018-10-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03511430
The ClinicalTrials.gov registry entry for NCT03511430 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 370 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Nevada, Reno, which has 23 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT03511430 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03511430 about?
NCT03511430 is a clinical study titled ""SVEAT" Chest Pain Scoring System". This is a prospective, observational study to assess the efficacy of the newly developed SVEAT scoring system in identifying low-risk patients who may be eligible for early discharge. Various elements of clinical information including Symptoms, Vascular history, EKG, Age and Troponin values will be ...
What is the current status of trial NCT03511430?
This trial is currently completed. The enrollment target is 370 participants. The study started on 2017-05-01. Estimated completion is 2018-10-10.
Who is sponsoring clinical trial NCT03511430?
This trial is sponsored by University of Nevada, Reno, which has 23 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.